[144] Thermo Fisher Scientific, Inc. SEC Filing

Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO) Rule 144 notice shows an insider proposes to sell 201 shares of common stock through Fidelity Brokerage, with an aggregate market value of $100,533.57 based on the filing. The shares are reported as acquired via an option granted on 02/26/2019 and exercised/dated 08/19/2025 with cash payment. The filer has aggregated recent dispositions: Marc N. Casper sold 10,000 shares on 08/06/2025 for $4,518,207.00 and 8,000 shares on 08/07/2025 for $3,635,549.60. The notice includes the standard insider representation that no material nonpublic information is known.

Insights

Securities Analyst

TL;DR: Insider plans a small Rule 144 sale after exercising options; significant recent sales by Marc N. Casper are notable for volume and proceeds.

The filing reports a proposed sale of 201 shares valued at $100,533.57, acquired via an option grant dated 02/26/2019 and recorded with an acquisition/exercise date of 08/19/2025. The proposed sale is routed through Fidelity on the NYSE. Recent reported transactions show total proceeds exceeding $8 million from sales of 18,000 shares by Marc N. Casper across two days, indicating meaningful liquidity events by an insider. For investors, the Rule 144 notice itself is routine compliance; the material element is the magnitude of the prior sales which may reflect portfolio diversification or other personal financial planning.

Corporate Governance Expert

TL;DR: The disclosure follows Rule 144 formality; the representation about absence of material nonpublic information is standard and required.

The form documents acquisition via option and a cash payment on the exercise date, and includes the attestation required under Rule 144. The existence of recent large sales by Marc N. Casper should prompt review of any open-window policies, blackout periods, or 10b5-1 plans, although none are explicitly stated here. The filing contains no indication of restricted transfers or unusual consideration, and it satisfies the regulatory notice of proposed sale requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	201	100533.57	377612121	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	Option Granted 02/26/2019	Issuer			201	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/06/2025	10000	4518207.00
Marc N. Casper 168 Third Avenue Waltham, MA 02451	Common	08/07/2025	8000	3635549.60

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Thermo Fisher Scientific (TMO) disclose?

The form discloses a proposed sale of 201 common shares through Fidelity with aggregate market value of $100,533.57, acquired via an option granted on 02/26/2019 and dated 08/19/2025.

Who acted as broker for the proposed sale on Form 144 for TMO?

The broker listed is Fidelity Brokerage Services LLC, address 900 Salem Street, Smithfield, RI, and the intended exchange is NYSE.

Have there been recent insider sales by company insiders in this filing?

Yes, Marc N. Casper sold 10,000 shares on 08/06/2025 for $4,518,207.00 and 8,000 shares on 08/07/2025 for $3,635,549.60.

How were the 201 shares to be sold acquired according to the filing?

They were acquired by an option grant (grant date 02/26/2019) with an acquisition/exercise date recorded as 08/19/2025, and payment was in cash.

Does the filing state whether the seller knows any material nonpublic information?

Yes, the signer represents that they do not know any material adverse nonpublic information regarding the issuer at the time of signing.